Medically important fungi respond to azole drugs: an update
- 1 August 2015
- journal article
- review article
- Published by Future Medicine Ltd in Future Microbiology
- Vol. 10 (8), 1355-1373
- https://doi.org/10.2217/fmb.15.47
Abstract
The increased numbers of patients with compromised immune systems in the last three decades have increased the chances of life-threatening fungal infections. Numerous antifungal drugs have been developed in the last 20 years to treat these infections. The largest group, the azoles, inhibits the synthesis of fungal sterols. The use of these fungistatic azoles has subsequently led to the emergence of acquired azole resistance. The most common mechanisms that result in azole resistance include the overexpression or mutation of the azole target enzyme, and overexpression of drug transporters that are responsible for azole efflux from cells. Additional, less-frequent mechanisms have also been identified. Understanding azole resistance mechanisms is crucial for current antifungal treatment and for the future development of new treatment strategies.Keywords
This publication has 99 references indexed in Scilit:
- Genetic Basis ofCandidaBiofilm Resistance Due to Drug‐Sequestering Matrix GlucanThe Journal of Infectious Diseases, 2010
- Calcineurin regulates innate antifungal immunity in neutrophilsThe Journal of Experimental Medicine, 2010
- Formation of new chromosomes as a virulence mechanism in yeast Candida glabrataProceedings of the National Academy of Sciences of the United States of America, 2009
- Functional analysis of Candida albicans GPI-anchored proteins: Roles in cell wall integrity and caspofungin sensitivityFungal Genetics and Biology, 2008
- Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus : the Challenge of Azoles versus EchinocandinsAntimicrobial Agents and Chemotherapy, 2008
- Candida albicans UPC2 is transcriptionally induced in response to antifungal drugs and anaerobicity through Upc2p-dependent and -independent mechanismsMicrobiology, 2008
- Mutations in the multi‐drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole‐resistant Candida albicans strainsMolecular Microbiology, 2008
- Resistance to echinocandin-class antifungal drugsDrug Resistance Updates, 2007
- Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicansScience, 2006
- Calcineurin is essential for survival during membrane stress in Candida albicansThe EMBO Journal, 2002